Related references
Note: Only part of the references are listed.Rheumatoid Factor as a Potentiator of Anti-Citrullinated Protein Antibody-Mediated Inflammation in Rheumatoid Arthritis
Jeremy Sokolove et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis
Christoph Boehler et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype
Kris Covens et al.
BLOOD (2013)
B-cell targeted therapeutics in clinical development
Stephan Blueml et al.
ARTHRITIS RESEARCH & THERAPY (2013)
B-1 B Cell Development in the Fetus and Adult
Encarnacion Montecino-Rodriguez et al.
IMMUNITY (2012)
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
Ulrike Harre et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Inflammatory bone loss: pathogenesis and therapeutic intervention
Kurt Redlich et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Should rheumatoid factor in rheumatoid arthritis be sent to Davy Jones's Locker?
E. Besada et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
P. P. Tak et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70-
Daniel O. Griffin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Combining anti-cyclic citrullinated peptide with the American College of Rheumatology 1987 criteria failed to improve early rheumatoid arthritis diagnosis in the community-based very early arthritis cohort
Xavier Le Loet et al.
RHEUMATOLOGY (2011)
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis
Maria D. Mjaavatten et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
E. C. Keystone et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Golimumab, a Human Anti-Tumor Necrosis Factor α Monoclonal Antibody, Injected Subcutaneously Every Four Weeks in Methotrexate-Naive Patients With Active Rheumatoid Arthritis Twenty-Four-Week Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Golimumab Before Methotrexate as First-Line Therapy for Early-Onset Rheumatoid Arthritis
Paul Emery et al.
ARTHRITIS AND RHEUMATISM (2009)
Autoantibodies and the Risk of Cardiovascular Events
Kimberly P. Liang et al.
JOURNAL OF RHEUMATOLOGY (2009)
Golimumab inpatients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
Josef S. Smolen et al.
LANCET (2009)
B-cell-directed therapies for autoimmune disease
Thomas Doerner et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems
Jennie Ursum et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Inverse Association Between Obesity and Antinuclear Antibodies in Women
Delia Almeida Gonzalez et al.
JOURNAL OF RHEUMATOLOGY (2008)
Measuring function in rheumatoid arthritis - Identifying reversible and irreversible components
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2006)
Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review
J. Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Immune complexes from rheumatoid arthritis synovial fluid induce Fc gamma RIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells
Linda Mathsson et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis
VPK Nell et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
L De Rycke et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
D Aletaha et al.
ARTHRITIS RESEARCH & THERAPY (2005)
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
JS Smolen et al.
RHEUMATOLOGY (2003)
Share Paper
